EP3041864
IL-18 bindiprótín (IL-18BP) í bólgusjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.9.2014EP published:
21.7.2021EP application number:
14759210.9
EP translation filed:
1.9.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
4.9.2034Expiry date:
4.9.2026Next due date:
30.9.2026
Title:
IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES
Timeline
Today
5.9.2014EP application
21.7.2021EP Publication
1.9.2021Translation submitted
15.9.2021Registration published
4.9.2026Expires
Owner
Name:
AB2 Bio SAAddress:
EPFL Innovation Park Building B, 4th Floor, 1015 Lausanne, CH
Inventor
Name:
PFEIFER, AndreaAddress:
CH-1806 St-Légier-La Chiésaz, CH
Name:
DEL VAL, GregAddress:
CH-1180 Rolle, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13183193Date:
5.9.2013Country:
EP
Classification
Categories:
C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 21.9.2021
Expires: 4.9.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 27.9.2022
Expires: 4.9.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.9.2023
Expires: 4.9.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.9.2024
Expires: 4.9.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.9.2025
Expires: 4.9.2026
Payer: Árnason Faktor ehf.